---
title: "Ennore Coke Ltd (512369) — Share Price, Financials & Analysis"
symbol: "512369"
company: "Ennore Coke Ltd"
canonical: "https://tapetide.com/stocks/512369"
isin: "INE755H01016"
bse_code: "512369"
sector: "Services"
industry: "Commercial Services & Supplies"
generated_at: "2026-10-13T10:59:39.835Z"
---

# Ennore Coke Ltd (512369)

Canonical page: https://tapetide.com/stocks/512369

## Company

- **BSE Code:** 512369
- **ISIN:** INE755H01016
- **Sector:** Services
- **Industry:** Commercial Services & Supplies
- **Macro Sector:** Services
- **Stock Type:** EQUITY
- **Listed Since:** 2006-07-25
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** ennorecoke.com

## About

Ennore Coke Limited is an India-based company, which is engaged in the business of manufacturing and trading of coke/coal and generation of power.

## Latest Price

- **Price:** ₹2.05
- **Change:** +0.06 (+3.02%)
- **Open:** ₹2.08
- **Day High:** ₹2.08
- **Day Low:** ₹2.05
- **Previous Close:** ₹1.99
- **Volume:** 1001
- **As Of:** 2020-05-21T21:13:34+00:00

## Key Insights

### Strengths

- Debtor days have improved from 278 to 88.9 days.

### Weaknesses

- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -66.4% over past five years.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | 77% | 2% | — |
| revenue growth | -94% | -82% | -66% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 158.14 | 50.92 | 9.22 | 3.42 | 7.02 | 1.23 | 1.01 | 0 | 0.47 | 0.1 | 0 | 0 |
| Expenses | 177.49 | 55.29 | 18.15 | 9.88 | 24.39 | 15.79 | 10.58 | 4.74 | 6.34 | 1.27 | 1.45 | 1.16 |
| Operating Profit | -19.35 | -4.37 | -8.93 | -6.46 | -17.37 | -14.56 | -9.57 | -4.74 | -5.87 | -1.17 | -1.45 | -1.16 |
| OPM % | -12.24 | -8.58 | -96.85 | -188.89 | -247.44 | -1183.74 | -947.52 | — | -1248.94 | -1170 | — | — |
| Other Income | 13.55 | 0.34 | 0.22 | 7.78 | 0 | 0 | 7.39 | 0 | 0 | 0.01 | 0 | 0.08 |
| Interest | 3.71 | 3.6 | 3.44 | 4.53 | 4.26 | 0 | 0 | 0.49 | -2.13 | 0 | 0 | 0 |
| Depreciation | 3.28 | 3.22 | 3.22 | 3.22 | 3.23 | 2.3 | 2.24 | 2.27 | 2.26 | 2.07 | 1.37 | 1.52 |
| Profit before tax | -12.79 | -10.85 | -15.37 | -6.43 | -24.86 | -16.86 | -4.42 | -7.5 | -6 | -3.23 | -2.82 | -2.6 |
| Tax % | -5.47 | 0 | 0 | 181.65 | 26.19 | 0 | 0 | 0 | -10 | 0 | 0 | 0 |
| Net Profit | -12.09 | -10.85 | -15.38 | -18.11 | -31.37 | -16.86 | -4.42 | -7.5 | -5.41 | -3.23 | -2.82 | -2.6 |
| EPS in Rs | -7.8 | -7 | -9.92 | -11.68 | -20.24 | -10.88 | -2.85 | -4.84 | -3.49 | -2.08 | -1.82 | -1.68 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 101 | 387 | 659 | 633 | 345 | 462 | 341 | 70 | 3 | 1 |
| Expenses | 100 | 357 | 640 | 596 | 373 | 505 | 419 | 108 | 35 | 10 |
| Operating Profit | 1 | 30 | 19 | 37 | -28 | -44 | -78 | -38 | -32 | -10 |
| OPM % | 1.4 | 8 | 2.8 | 6 | -8 | -9 | -23 | -54 | -1193 | -1693 |
| Other Income | 0 | 2 | 27 | 7 | 11 | 39 | 52 | 11 | 8 | 0 |
| Interest | 1 | 13 | 29 | 23 | 19 | 16 | 15 | 16 | 1 | -2 |
| Depreciation | 0 | 5 | 9 | 15 | 16 | 15 | 13 | 13 | 9 | 7 |
| Profit before tax | 0 | 14 | 7 | 5 | -53 | -35 | -54 | -55 | -34 | -15 |
| Tax % | 67 | 35 | 35 | 58 | -25 | 2 | -1 | 33 | -2 | — |
| Net Profit | 0 | 9 | 5 | 2 | -40 | -36 | -54 | -73 | -34 | -14 |
| EPS in Rs | 0.05 | 5.96 | 3.13 | 1.3 | -25.67 | -23.3 | -34.61 | -47.17 | -21.69 | -9.07 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Sep 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves | 13 | 29 | 33 | 35 | -4 | -41 | -94 | -167 | -201 | -207 |
| Borrowings | 88 | 104 | 199 | 261 | 392 | 391 | 345 | 340 | 337 | 337 |
| Other Liabilities | 82 | 207 | 299 | 367 | 411 | 472 | 116 | 89 | 39 | 39 |
| Total Liabilities | 198 | 354 | 547 | 680 | 814 | 839 | 382 | 277 | 190 | 184 |
| Fixed Assets | 3 | 67 | 59 | 107 | 100 | 87 | 77 | 64 | 55 | 57 |
| CWIP | 102 | 60 | 61 | 0 | 0 | 1 | 4 | 5 | 5 | 0 |
| Investments | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 92 | 228 | 427 | 573 | 714 | 751 | 301 | 208 | 130 | 128 |
| Total Assets | 198 | 354 | 547 | 680 | 814 | 839 | 382 | 277 | 190 | 184 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 31 | -17 | 48 | -102 | 25 | -86 | -34 | 86 | 1 | 1 |
| Cash from Investing Activity | -44 | -58 | -41 | 19 | -6 | -21 | 45 | -6 | 19 | 4 |
| Cash from Financing Activity | 4 | 75 | 6 | 89 | -37 | 109 | -14 | -80 | -20 | -5 |
| Net Cash Flow | -9 | 0 | 13 | 6 | -18 | 2 | -4 | 0 | 0 | 0 |
| Free Cash Flow | -10 | -72 | 40 | -105 | 23 | -94 | -37 | 80 | 0 | 1 |
| CFO/OP | -62920 | -1149 | 162 | -526 | 70 | 305 | 70 | -112 | -3 | -2 |

### Ratios

| Item | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | — | 102 | 102 | 30 | 220 | 355 | 254 | 190 | 555 | 89 |
| Inventory Days | — | 127 | 64 | 77 | 43 | 68 | 144 | 67 | 108 | 3 |
| Days Payable | — | 281 | 191 | 3 | 192 | 274 | 304 | 91 | 262 | 230 |
| Cash Conversion Cycle | — | -52 | -24 | 104 | 71 | 149 | 93 | 166 | 400 | -139 |
| Working Capital Days | — | 28 | -24 | -2 | -12 | -182 | -64 | 42 | 18 | -2240 |
| ROCE % | 0 | 2 | 20 | 18 | 10 | -8 | -5 | -12 | -17 | -20 |

## Shareholding Pattern

### annual

| Category | Mar 2017 | Dec 2017 |
| --- | --- | --- |
| Promoters | 61.77% | 61.77% |
| DIIs | 6.29% | 6.29% |
| Public | 31.95% | 31.95% |
| No. of Shareholders | 3178 | 2598 |

### Quarterly

| Category | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 61.77% | 61.77% | 61.77% | 61.77% | 61.77% | 61.77% | 61.77% |
| DIIs | 6.29% | 6.29% | 6.29% | 6.29% | 6.29% | 6.29% | 6.29% |
| Public | 31.95% | 31.95% | 31.95% | 31.95% | 31.95% | 31.95% | 31.95% |
| No. of Shareholders | 3159 | 3159 | 3174 | 3178 | 3177 | 3204 | 2598 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 4 / 4 / 11

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 222.49 | Buy |
| EMA (10) | 227 | Sell |
| SMA (20) | 245.58 | Sell |
| EMA (20) | 241.42 | Sell |
| SMA (50) | 283.85 | Sell |
| EMA (50) | 276.08 | Sell |
| SMA (100) | 324.78 | Sell |
| EMA (100) | 308.81 | Sell |
| SMA (200) | 360.51 | Sell |
| EMA (200) | 343.31 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 37.55 | Neutral |
| MACD (12,26,9) | -19.87 | Buy |
| Stochastic (14,3,3) | 18.4 | Buy |
| ADX (14) | 37.51 | Buy |
| Williams %R (14) | -74.5 | Neutral |
| ATR (14) | 13.24 | High Volatility |
| ROC (12) | -7.12 | Sell |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 43.74 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 2026-03-06 | [Announcement under Regulation 30 (LODR)-Updates on Acquisition](https://www.bseindia.com/xml-data/corpfiling/AttachLive/ae31b2de-809d-47ee-a10b-b4bcadafb317.pdf) |
| 2026-02-20 | [Investor Meet On Alkem Medtech'S Strategic Way Forward - Video Recording.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/497ab042-2524-4f62-a329-2d8a8c82de76.pdf) |
| 2026-02-18 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b4778b50-6dd4-4b8c-96a6-cdb9511b3988.pdf) |
| 2026-02-17 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/xml-data/corpfiling/AttachHis/81976416-6524-4e7b-ab63-b4ac522f7919.pdf) |
| 2026-02-16 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a15cf9d7-1ac0-4b20-bb95-fc49544c1487.pdf) |
| 2026-02-16 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/xml-data/corpfiling/AttachHis/53c93086-b4dd-4832-a634-9bae3e40762e.pdf) |
| 2026-02-16 | [USFDA Inspection At The Manufacturing Facility Of Enzene Biosciences Limited, A Subsidiary Of The Company In India Located At Chakan, Pune - Update](https://www.bseindia.com/xml-data/corpfiling/AttachLive/dc69f515-1982-446a-b3ea-aa6fc3d94caa.pdf) |
| 2026-02-14 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/xml-data/corpfiling/AttachLive/5f26eacd-1b52-4689-8d1f-3c9388b214b9.pdf) |
| 2018-03-31 | [Liquidation Order](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72b2853b-d443-45d7-9c7e-9ed19cbff253.pdf) |
| 2018-03-31 | [Liquidation Order](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/3/72b2853b-d443-45d7-9c7e-9ed19cbff253.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| 2025 | [Financial Year 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/08670de9-d763-4d1b-9412-f1524ad094d0.pdf) |
| 2024 | [Financial Year 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/92259065-d6cd-48d1-9d2c-d5dd267da373.pdf) |
| 2024 | Financial Year 2024 |
| 2023 | [Financial Year 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/47d6d4cd-bda8-42fb-aa1a-bed89d89e2dc.pdf) |
| 2023 | Financial Year 2023 |
| 2022 | [Financial Year 2022](https://www.bseindia.com/bseplus/AnnualReport/539523/73601539523.pdf) |
| 2021 | [Financial Year 2021](https://www.bseindia.com/bseplus/AnnualReport/539523/68948539523.pdf) |
| Mar 2020 | [Financial Year 2020](https://www.bseindia.com/bseplus/AnnualReport/539523/5395230320.pdf) |
| Mar 2019 | [Financial Year 2019](https://www.bseindia.com/bseplus/AnnualReport/539523/5395230319.pdf) |
| Mar 2018 | [Financial Year 2018](https://www.bseindia.com/bseplus/AnnualReport/539523/5395230318.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Feb 2026 | [Concall - Feb 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b4778b50-6dd4-4b8c-96a6-cdb9511b3988.pdf) |
| Feb 2026 | [Concall - Feb 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a15cf9d7-1ac0-4b20-bb95-fc49544c1487.pdf) |
| Feb 2026 | [Concall - Feb 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/535e4722-853b-4f09-832f-7a5b3c2be1b2.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ecd03561-909d-4fcd-b57b-fb455bd2da51.pdf) |
| Aug 2025 | [Concall - Aug 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0cd83f78-d535-4c6a-85a2-5f4a74bb6a9c.pdf) |
| Jun 2025 | [Concall - Jun 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ee0be198-db18-479e-88c2-1338f8249b2f.pdf) |
| Mar 2025 | [Concall - Mar 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/111cd47b-bf95-48b5-87c1-5a8fbed12ef4.pdf) |
| Feb 2025 | [Concall - Feb 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/667168ff-f380-4900-b24c-305bf284e725.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/42c6bd93-e92a-4faf-a759-d5d6eaad0470.pdf) |
| Sep 2024 | [Concall - Sep 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b55029a5-57d1-46ab-b826-fb2cc20bb124.pdf) |

### Credit Rating Reports

| Date | Document |
| --- | --- |
| 2026-02-24 | Credit rating update — CRISIL |
| 2026-02-06 | Credit rating update — India Ratings |
| 2026-01-05 | Credit rating update — CARE Ratings |
| 2025-09-15 | Credit rating update — CRISIL |
| 2025-04-14 | Credit rating update — Brickwork Ratings |
| 2025-02-07 | Credit rating update — India Ratings |
| 2025-01-08 | Credit rating update — CARE Ratings |
| 2024-09-19 | Credit rating update — CRISIL |
| 2024-01-18 | Credit rating update — Brickwork Ratings |
| 2022-10-18 | Credit rating update — Brickwork Ratings |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-10-13T10:59:39.835Z.